Fredun Pharmaceuticals Quarterly Results for Trading Insights
FREDUN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹9 Cr
QSept 2025
Fredun Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹144 Cr in Sept 2025 (-12.7% vs Mar 2025)
- Net Profit of ₹9 Cr in Sept 2025 (+50.0% vs Mar 2025)
- EBITDA of ₹21 Cr in Sept 2025 (+40.0% vs Mar 2025)
- Operating Margin of 14.0% in Sept 2025 (+5.0pp vs Mar 2025)
- Earnings Per Share of ₹19.98 in Sept 2025 (+57.2% vs Mar 2025)
Fredun Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 144 | 165 | 119 | 0 | 0 | -12.7% | - |
| Net Profit (₹ Cr) | 9 | 6 | 7 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 21 | 15 | 17 | 0 | 0 | - | - |
| EPS (₹) | 19.98 | 12.71 | 14.33 | 0.00 | 0.00 | - | - |
| Operating Margin (%) | 14.0% | 9.0% | 14.0% | 0.0% | 0.0% | - | - |
Fredun Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Fredun Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Fredun Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Fredun Pharmaceuticals
Additional stock information and data for FREDUN
Revenue Trend (₹ Cr)
Sept 2024
0
Jun 2025
119
Mar 2025
165
Sept 2025
144
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
7
Mar 2025
6
Sept 2025
9
Operating Margin Trend (%)
Sept 2024
0.0%
Jun 2025
14.0%
Mar 2025
9.0%
Sept 2025
14.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Fredun Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores